日批在线视频_内射毛片内射国产夫妻_亚洲三级小视频_在线观看亚洲大片短视频_女性向h片资源在线观看_亚洲最大网

US EUROPE AFRICA ASIA 中文
Business / Baby formula

China's mums key to Nestle baby milk deal

(Agencies) Updated: 2012-04-25 11:19

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

Hot Topics

Editor's Picks
...
主站蜘蛛池模板: 日韩一区二区三区视频在线观看 | 91美女精品网站 | 欧美黄色大片在线观看 | 一区二区三区免费视频观看 | 制服av网| 玖玖精品 | 超碰人人人人人人 | 白天操晚上操天天操 | 日本黄色小视频 | 九九精品视频在线观看 | 欧美国产日韩在线观看 | 九九伦理 | 97超碰中文字幕 | 国产精品久久久久久一区二区三区 | 免费黄视频在线观看 | 国产女主播喷水视频在线观看 | 色多多在线视频 | 国产成人精品av | 最近日韩免费视频 | av毛片在线播放 | 男人天堂a | 奇米影视久久 | 欧美xxxx网站 | 日本精品中文字幕 | 91网站在线观看视频 | 亚洲精品视频久久 | 成人免费精品 | 色哟哟亚洲 | 红桃视频国产精品 | 久久在线视频 | 五月天婷婷综合 | 欧美一级片免费在线观看 | 96av视频| 狠狠爱av | 一区二区三区视频免费看 | 日本精品国产 | 黄色一级视频免费 | 神马久久久久久久久久 | 精品久久久久久久久久久久久久久 | 国产91在线高潮白浆在线观看 | 91亚洲综合 |